Biotech Brass Misled Investors About Cancer Drugs, Suit Says
By Sydney Price · November 13, 2024, 7:17 PM EST
Executives and directors of biotechnology company Agenus Inc. have been hit with a shareholder derivative suit in Massachusetts federal court alleging that the company misled investors about the effectiveness of its...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login